Literature DB >> 21691122

Soft bone - hard arteries: a link?

Gérard M London1.   

Abstract

Chronic kidney disease is characterized by mineral and various bone disorders associated with extraosseous and cardiovascular calcifications. Experimental studies and clinical observations in the general population and in chronic kidney disease patients show an inverse relationship between the extent of cardiovascular calcifications and bone mineral density or bone metabolic activity. Arterial calcification and osteoporosis are frequently observed in the same subjects and progress in parallel in postmenopausal women, and associations between histomorphometric indices of bone activity and vascular calcifications were also observed in patients with chronic and end-stage kidney diseases. The biological linkage between vascular calcifications and bone changes is certainly a part of the aging process, but in many studies these bone-vascular associations remained significant after adjustment for age, which suggests an age-independent causal relationship. Based on clinical and experimental evidence showing an association between bone disorders and functional and structural changes of the arterial system the concept of a bone-vascular axis was established complementary to the classical kidney-bone axis. Nevertheless, the factors or mechanisms accounting for these associations are not well understood, and could result from (1) arterial disease responsible for bone abnormalities; (2) action of common dysmetabolic or 'toxic' factors and mechanisms acting on bones and vessels, or (3) direct or indirect influence of bone cells and metabolism on the arterial system. This short review aims to illustrate these possible mechanisms.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21691122     DOI: 10.1159/000327004

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  8 in total

Review 1.  The Key Role of the Blood Supply to Bone.

Authors:  Massimo Marenzana; Timothy R Arnett
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

2.  A case of ischemic osteopathy in a hemodialysis patient with advanced peripheral artery disease.

Authors:  Shunsuke Yamada; Toshiaki Nakano; Hiromasa Kitamura; Takanari Kitazono
Journal:  CEN Case Rep       Date:  2019-10-21

3.  Incidence and risk factors for hip fractures in dialysis patients.

Authors:  M Maravic; A Ostertag; P U Torres; M Cohen-Solal
Journal:  Osteoporos Int       Date:  2013-07-09       Impact factor: 4.507

4.  Icariin attenuates hypoxia-induced oxidative stress and apoptosis in osteoblasts and preserves their osteogenic differentiation potential in vitro.

Authors:  H-P Ma; X-N Ma; B-F Ge; P Zhen; J Zhou; Y-H Gao; C J Xian; K-M Chen
Journal:  Cell Prolif       Date:  2014-10-30       Impact factor: 6.831

5.  Lack of association of oral calcium supplementation with coronary artery calcification in rheumatoid arthritis.

Authors:  Laura Geraldino-Pardilla; Shanthi Dhaduvai; Jon T Giles; Joan M Bathon
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

6.  Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice.

Authors:  Sohel Shamsuzzaman; Melda Onal; Hillary C St John; J Wesley Pike
Journal:  J Cell Biochem       Date:  2017-05-30       Impact factor: 4.429

7.  Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions.

Authors:  D Canoy; N C Harvey; D Prieto-Alhambra; C Cooper; H E Meyer; B O Åsvold; M Nazarzadeh; K Rahimi
Journal:  Osteoporos Int       Date:  2021-10-13       Impact factor: 5.071

8.  Prevalence of Vertebral Fractures and Their Prognostic Significance in the Survival in Patients with Chronic Kidney Disease Stages 3‒5 Not on Dialysis.

Authors:  Cristina Castro-Alonso; Luis D'Marco; Jaume Pomes; Monserrat Del Amo Conill; Ana Isabel García-Diez; Pablo Molina; María Jesús Puchades; José Manuel Valdivielso; Verónica Escudero; Jordi Bover; Juan Navarro-González; Begoña Ribas; Luis Manuel Pallardo; José Luis Gorriz
Journal:  J Clin Med       Date:  2020-05-25       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.